Gilead logo

FDA extends approval of remdesivir to encompass non-hospitalized high-risk

AbbVie

FDA approves second indication of AbbVie’s Skyrizi for adults with active psoriatic arthritis

BD

BD boasts of a landmark advancement in flow cytometry

Zymeworks

Zymeworks to cut headcount at least 25% by end of 2022

Altos

Biotech Altos Labs emerges with $3B in funding to focus on ‘cellular rejuvenation programming’

Beckman Coulter

Beckman Coulter Life Sciences wins IVDR for flow cytometry reagents

Valneva vaccine vials

Valneva shares surge 30% after announcing its vaccine candidate neutralized omicron in neutralizing antibody study

Sorrento Therapeutics

Brazilian regulators authorize Sorrento Phase 2 clinical trial of COVI-MSC in COVID-19 long-haulers

AstraZeneca/Daiichi-Sankyo

FDA grants Enhertu priority review for HER2-positive positive metastatic breast cancer